nVerses Capital LLC Grows Position in Chemed Co. (NYSE:CHE)

nVerses Capital LLC increased its position in shares of Chemed Co. (NYSE:CHE) by 16.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 700 shares of the company’s stock after buying an additional 100 shares during the quarter. nVerses Capital LLC’s holdings in Chemed were worth $421,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Cabot Wealth Management Inc. grew its stake in Chemed by 0.9% during the 3rd quarter. Cabot Wealth Management Inc. now owns 22,961 shares of the company’s stock worth $13,799,000 after buying an additional 202 shares during the last quarter. NBC Securities Inc. lifted its position in Chemed by 21.6% during the 3rd quarter. NBC Securities Inc. now owns 671 shares of the company’s stock worth $403,000 after acquiring an additional 119 shares during the period. Creative Planning lifted its position in Chemed by 57.3% during the 3rd quarter. Creative Planning now owns 1,932 shares of the company’s stock worth $1,161,000 after acquiring an additional 704 shares during the period. ORG Partners LLC lifted its position in Chemed by 12.8% during the 3rd quarter. ORG Partners LLC now owns 484 shares of the company’s stock worth $291,000 after acquiring an additional 55 shares during the period. Finally, Sound Income Strategies LLC acquired a new stake in Chemed during the 3rd quarter worth approximately $201,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Activity

In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at $3,363,864.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at $3,363,864.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 9,144 shares of company stock valued at $5,264,839 in the last three months. 3.32% of the stock is currently owned by company insiders.

Chemed Trading Up 0.9 %

Chemed stock opened at $612.59 on Friday. Chemed Co. has a twelve month low of $502.64 and a twelve month high of $654.62. The stock has a 50 day moving average of $583.19 and a two-hundred day moving average of $571.49. The stock has a market capitalization of $9.27 billion, a price-to-earnings ratio of 32.97, a PEG ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. During the same period in the previous year, the business posted $4.71 earnings per share. The firm’s revenue was up 7.6% compared to the same quarter last year. Equities analysts predict that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio (DPR) is currently 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.